Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplastic Cells, Circulating × Lapatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 23 Neoplasms 3 Neoplasm Metastasis 3 Stomach Neoplasms 1 Sarcoma 1 Osteitis Deformans 1 Neoplastic Cells, Circulating 1 Invasive Breast Cancer 1 Head and Neck Neoplasms 1 HER2-positive Advanced Breast Cancer 1 HER2+ Metastatic Breast Cancer (MBC) 1 HER2 Positive Metastatic Breast Cancer 1 Esophageal Neoplasms 1 Carcinoma 1 Breast Neoplasms, Male 1 Brain Neoplasms 1

Interventions

Folfox protocol 2 Standard of Care 1 Lapatinib 1 Drug Therapy 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01619111 2024-06-04

DETECT III

University of Ulm

Phase 3 Completed

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡